SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of NRx Pharmaceuticals, Inc. and Encourages Long-Term NRXP / BRPA Shareholders to Contact the Firm
Provided By PR Newswire
Last update: Jun 15, 2023
PHILADELPHIA, June 15, 2023 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) ("NRx") on behalf of the company's long-term shareholders.
Read more at prnewswire.com
